Skip to Main Content

Paper Details

Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML.
Leukemia
10
2019
Creatine, Creatine kinase, EVI1, EVI1-positive AML, GSK3, WNT
Author NameAffiliation
Lina BenajibaDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Lina BenajibaThe Broad Institute of Harvard University and Massachusetts Institute of Technology
Lina BenajibaINSERM U3 and CNRS 8254, Imagine Institute, Universite Paris Saclay
Gabriela AlexeDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Gabriela AlexeBoston University
Gabriela AlexeThe Broad Institute of Harvard University and Massachusetts Institute of Technology
Gabriela AlexeDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Gabriela AlexeThe Broad Institute of Harvard University and Massachusetts Institute of Technology
Gabriela AlexeBoston University
Angela SuINSERM UMR , Institut Universitaire d'Hematologie
Emmanuel RaffouxAssistance Publique - Hopitaux de Paris
Jean SoulierAssistance Publique - Hopitaux de Paris
Raphael ItzyksonINSERM UMR , Institut Universitaire d'Hematologie
Raphael ItzyksonAssistance Publique - Hopitaux de Paris
Kimberly StegmaierDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Kimberly StegmaierThe Broad Institute of Harvard University and Massachusetts Institute of Technology
Kimberly StegmaierDana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School
Kimberly StegmaierThe Broad Institute of Harvard University and Massachusetts Institute of Technology
Alexandre PuissantINSERM UMR , Institut Universitaire d'Hematologie
  • 1 - 19

Datasets